These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3295764)

  • 21. Effects of ethanol on drug and metabolite pharmacokinetics.
    Lane EA; Guthrie S; Linnoila M
    Clin Pharmacokinet; 1985; 10(3):228-47. PubMed ID: 2861929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation.
    Gilmore IT; Hofmann AF
    Gastroenterology; 1980 Jan; 78(1):177-9. PubMed ID: 7350025
    [No Abstract]   [Full Text] [Related]  

  • 23. Biological determinants of altered pharmacokinetics in the elderly.
    Shand DG
    Gerontology; 1982; 28 Suppl 1():8-17. PubMed ID: 7044905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics in the 1980s.
    Balant LP
    Clin Ther; 1984; 6(2):112-24. PubMed ID: 6705009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic contributions to drug use.
    Chan K
    J Clin Hosp Pharm; 1985 Sep; 10(3):257-67. PubMed ID: 3905867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.
    Le Couteur DG; McLean AJ
    Clin Pharmacokinet; 1998 May; 34(5):359-73. PubMed ID: 9592620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug disposition in liver disease.
    Shand DG
    N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs and the liver.
    Reidenberg MM; Breckenridge A
    Clin Pharmacol Ther; 1998 Oct; 64(4):353-4. PubMed ID: 9797790
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug prescribing in hepatobiliary disease.
    Roberts RK; Desmond PV; Schenker S
    Drugs; 1979 Mar; 17(3):198-212. PubMed ID: 378647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive assessment in vivo of hepatic drug metabolism in health and disease.
    Vesell ES
    Ann N Y Acad Sci; 1984; 428():293-307. PubMed ID: 6378027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-induced modifications of drug pharmacokinetics.
    Barre J; Houin G; Brunner F; Bree F; Tillement JP
    Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive methods for the assessment of hepatic drug disposition.
    Bircher J
    Int J Clin Pharmacol Res; 1983; 3(6):415-9. PubMed ID: 6432711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic first-pass metabolism in liver disease.
    Blaschke TF; Rubin PC
    Clin Pharmacokinet; 1979; 4(6):423-32. PubMed ID: 391462
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of some disease states on drug disposition.
    Wilson K; Bromberg T
    Methods Find Exp Clin Pharmacol; 1981; 3(3):189-200. PubMed ID: 7253775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of liver metabolic function. Clinical implications.
    Brockmöller J; Roots I
    Clin Pharmacokinet; 1994 Sep; 27(3):216-48. PubMed ID: 7988103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatotoxicity in patients with liver disease.
    Andreasen PB
    Arch Toxicol Suppl; 1978; (1):131-6. PubMed ID: 277091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.